This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs), particularly in the development of drugs targeting neurological disorders and cardiovascular diseases. Its chiral structure makes it valuable for creating enantiomerically pure compounds, which are crucial for ensuring the efficacy and safety of medications. Additionally, it is employed in research settings for studying enzyme interactions and receptor binding activities, aiding in the discovery of new therapeutic agents. Its fluorophenyl group enhances its ability to interact with biological targets, making it a key component in drug design and development.